Table 1 Patient characteristics
Factors | LAC-E group | OC-E group | LAC-NE group | LAC-E vs OC-E | LAC-E vs LAC-NE |
|---|---|---|---|---|---|
(n = 85) | (n = 25) | (n = 358) | P-value | P-value | |
Age (years, mean ± SD) | 84 ± 4 | 84 ± 4 | 65 ± 11 | NS | < .01 |
Gender | |||||
M | 42 | 11 | 227 | NS | < .05 |
F | 43 | 14 | 131 | ||
ASA-PS | |||||
1 or 2 | 65 (76%) | 19 (76%) | 341 (95%) | NS | < .01 |
3 or more | 20 (24%) | 6 (24%) | 17 (5%) | ||
Presence of symptom | 61 (72%) | 22 (88%) | 214 (60%) | NS | < .05 |
Previous abdominal surgery | 23 (27%) | 6 (24%) | 123 (34%) | NS | NS |
Comorbidities | |||||
Overall comorbidity | 53 (62%) | 15 (60%) | 163 (46%) | NS | < .05 |
Cardiac disease | 15 (18%) | 5 (20%) | 27 (8%) | NS | < .01 |
Hypertension | 33 (39%) | 9 (36%) | 81 (23%) | NS | < .01 |
Diabetes Mellitus | 10 (12%) | 3 (12%) | 52 (15%) | NS | NS |
Respiratory disease | 7 (8%) | 3 (12%) | 14 (4%) | NS | NS |
Renal disease | 6 (7%) | 1 (1%) | 10 (3%) | NS | NS |
Cerebrovascular disease | 5 (6%) | 1 (1%) | 5 (1%) | NS | < .05 |
Preoperative chemotherapy | 2 (2%) | 1 (1%) | 18 (5%) | NS | NS |
Postoperative chemotherapy | 8 (9%) | 4 (16%) | 127 (35%) | NS | < .01 |